A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer

• 1 January 2001
• journal article
• review article
• Published by National Institute for Health and Care Research in Health Technology Assessment
• Vol. 5  (32) , 1-195
• https://doi.org/10.3310/hta5320

Abstract

Keywords

• GEMCITABINE
• LUNG
• VINORELBINE
• DOCETAXEL
• PACLITAXEL
• PUBLISHED
• SYSTEMATIC REVIEW
• RAPID AND SYSTEMATIC
• ASSESSMENT VOLUME
• HEALTH TECHNOLOGY

Funding Information

• Health Technology Assessment Programme (00/14/01)